Next Article in Journal
4-[(2-Hydroxy-4-pentadecylbenzylidene)amino]-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one
Previous Article in Journal
Nꞌ-{[2-(Piperidin-1-yl)quinolin-3-yl]methylene}pyridine-4-carbohydrazide
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

Ethyl 3-{2-[(3-Methyl-1H-indol-2-yl)carbonyl]­hydrazinylidene}­butanoate

by
Thoraya A. Farghaly
and
Sobhi M. Gomha
*
Department of Chemistry, Faculty of Science, University of Cairo, Giza 12613, Egypt
*
Author to whom correspondence should be addressed.
Molbank 2012, 2012(1), M749; https://doi.org/10.3390/M749
Submission received: 6 January 2012 / Accepted: 4 February 2012 / Published: 7 February 2012

Abstract

:
The title compound, ethyl 3-{2-[(3-methyl-1H-indol-2-yl)carbonyl]hydrazinylidene}butanoate (3), was prepared via reaction of 3-methyl-1H-indole-2-carbohydrazide (1) and ethyl 3-oxo¬butanoate (2) under reflux. The structure of the synthesized compound was assigned on the basis of elemental analysis, IR, 1H-NMR, mass spectral and X-ray data.

Graphical Abstract

Indoles are among the most important nitrogen-containing heterocyclic molecules, found extensively in biological systems which play a vital role in biochemical processes. The indole ring system is found in many natural products, pharmaceutical agents and polymer materials [1,2,3,4,5,6,7]. The interesting chemical properties of indole have inspired chemists to design and synthesize a variety of indole derivatives [8]. In view of this finding, in the present paper we describe the synthesis of a new indole derivative with expected biological activity.

Results and Discussion

3-Methyl-1H-indole-2-carbohydrazide (1) [9] was allowed to react with ethyl 3-oxobutanoate (2) in ethanolic solution under reflux. The expected product of this reaction was assumed to be one of the seven structures 39 shown in Scheme 1. IR, 1H-NMR, mass spectral data and single-crystal X-ray diffraction studies (Figure 1 and Table 1) of the isolated product were in full agreement with the structure 3, but not with the other structures 49.

Crystallographic Analysis

The crystals were mounted on a glass fiber. All measurements were performed on an ENRAF NONIUS FR 590. The data were collected at a temperature of 25 °C using the ω scanning technique to a maximum of a 20 of 22.986°. The structure was solved by direct method using SIR 92 and refined by full-matrix least squares. Non-hydrogen atoms were refined anisotropically. Hydrogen atoms were located geometrically and were refined isotropically [10].

Crystal Data for Compound 3

C16H19N3O3, M = 301.346, monoclinic, a = 19.3108 (8), b = 7.7168 (4), c = 21.0944 (10) Ao, v = 3131.2 (3), α = γ = 90.00°, β = 95.065 (3)°, space group: P21/c, Z=8, Dx = 1.279 Mg m−3 reflection 937 measured, θmax = 27.50°. Figure 1 illustrates the structure as determined [10].

Synthesis of Ethyl 3-{2-[(3-Methyl-1H-indol-2-yl)carbonyl]hydrazinylidene}butanoate (3)

A mixture of the hydrazide 1 (1.89 g, 10 mmol) and ethyl 3-oxobutanoate 2 (10 mmol) in absolute ethanol (20 mL) was heated at reflux temperature for 2 h. The reaction mixture was then cooled and the formed precipitate was filtered off, washed with ethanol to afford the title compound 3. Yield: 84%; yellow microcrystals (from ethanol); mp: 238–240 °C. IR (KBr): v 1706, 1668 (2 C=O), 3409, 3234 (2 NH) cm−1. 1H NMR (DMSO-d6): δ 1.24 (t, J = 7.0 Hz, 3H, CH3), 2.03 (s, 3H, CH3), 2.53 (s, 3H, CH3), 3.43 (s, 2H, CH2), 4.23 (q, J = 7.0 Hz, 2H, CH2), 6.87–7.98 (m, 4H, ArH ), 10.38 (s, 1H, D2O exchangeable, NH), 11.21 (s, 1H, D2O exchangeable, NH). MS m/z (%): 301 (M+, 42), 189 (100), 155 (318), 117 (46), 77 (21).
Anal. Calcd for C16H19N3O3 (301.34): C, 63.77; H, 6.36; N, 13.94. Found C, 63.39; H, 6.46; N, 13.65.

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3

References and Notes

  1. Ismail, M.F.; Shmeiss, N.A.M.M.; El-Diwani, H.I.; Arbid, M.S. Synthesis and pharmacological activity of some 2,3-diphenylindole derivative. Indian J. Chem. Sect. B 1997, 36B, 288–292. [Google Scholar]
  2. von Angerer, E.; Knebel, N.; Kager, M.; Ganss, B.J. 1-(Aminoalkyl)-2-phenylindoles as novel pure Estrogen Antagonists. J. Med. Chem. 1900, 33, 2635–2640. [Google Scholar] [CrossRef]
  3. Biberger, C.; Von Angerer, E.J. 1-benzyl-2-phenylindole- and 1,2-diphenylindole-based antiestrogens. Estimation of agonist and anatagonist activities in transfection assays. J. Steroid Biochem. Mol. Bio. 1998, 64, 277–281. [Google Scholar] [CrossRef]
  4. Stevenson, G.I.; Smith, A.L.; Lewis, S.; Michie, S.G.; Neduvelil, J.G.; Patel, S.; Marwood, R.; Castro, J.L. 2-Aryl tryptamines: Selective high-affinity antagonists for the h5-HT2A receptor. Bioorg. Med. Chem. Lett. 2000, 10, 2697–2699. [Google Scholar] [CrossRef]
  5. Smith, A.L.; Stevenson, G.I.; Swain, C.J.; Castro, J.L. Tracelless solid phase synthesis of 2,3- disubstituted indoles. Tetrahedron Lett. 1998, 39, 8317–8320. [Google Scholar] [CrossRef]
  6. Casapullo, A.; Bifulco, G.; Bruno, I.; Riccio, R. New bisindole alkaloids of the Topsentin and Hamacanthin classes from the mediterranean marine sponge Rhaphisia lacazei. J. Nat. Prod. 2000, 63, 447–451. [Google Scholar] [CrossRef] [PubMed]
  7. Kaniwa, K.; Arai, M.A.; Li, X.; Ishibashi, M. Synthesis, determination of stereochemistry, and evaluation of new bisindole alkaloids from the myxomycete Arcyria ferruginea: An approach for Wnt signal inhibitor. Bioorg. Med. Chem. Lett. 2007, 17, 4254–4257. [Google Scholar] [CrossRef] [PubMed]
  8. Gribble, G.W.J. Recent developments in indole ring synthesis-methodology and applications. J. Chem. Soc. Perkin Trans. 1 2000, 1045–1075. [Google Scholar] [CrossRef]
  9. Acheson, R.M.; Prince, R.J.; Proctor, G. Two novel indole rearrangements. J. Chem. Soc. Perkin Trans. 1 1979, 595–598. [Google Scholar] [CrossRef]
  10. Crystal data for compound 3 ref. CCDC 846358 can be obtained on request from the director, Cambridge Crystallographic Data Center, 12 Union Road, Cambridge CB2 1EW, UK.
Scheme 1. Synthesis of the title compound (3).
Scheme 1. Synthesis of the title compound (3).
Molbank 2012 m749 sch001
Figure 1. The X-ray crystal structure of compound 3.
Figure 1. The X-ray crystal structure of compound 3.
Molbank 2012 m749 g001
Table 1. Selected bond lengths and bond angles in the ORTEP representation of compound 3 in the crystal. The crystallographic numbering does not reflect systematic numbering.
Table 1. Selected bond lengths and bond angles in the ORTEP representation of compound 3 in the crystal. The crystallographic numbering does not reflect systematic numbering.
Bond length, ÅBond length, ÅBond length, Å
C7—C15, 1.472N6—C14, 1.286C12—C17, 1.517
N5—C7, 1.359C14—C21, 1.487O1—C17, 1.337
N5—N6. 1.380C12—C14, 1.493O1—C20, 1.450
Angle (ω) Angle (ω) Angle (ω)
C17—O1—C20, 115.7O2—C7—N5, 117.4N23—C10—C8, 108.4
C10—N23—C15, 108.5O2—C7—C15, 120.3N23—C10—C13, 129.4
N6—N5—C7, 121.0N5—C7—C15, 122.3C8—C10—C13, 122.2

Share and Cite

MDPI and ACS Style

Farghaly, T.A.; Gomha, S.M. Ethyl 3-{2-[(3-Methyl-1H-indol-2-yl)carbonyl]­hydrazinylidene}­butanoate. Molbank 2012, 2012, M749. https://doi.org/10.3390/M749

AMA Style

Farghaly TA, Gomha SM. Ethyl 3-{2-[(3-Methyl-1H-indol-2-yl)carbonyl]­hydrazinylidene}­butanoate. Molbank. 2012; 2012(1):M749. https://doi.org/10.3390/M749

Chicago/Turabian Style

Farghaly, Thoraya A., and Sobhi M. Gomha. 2012. "Ethyl 3-{2-[(3-Methyl-1H-indol-2-yl)carbonyl]­hydrazinylidene}­butanoate" Molbank 2012, no. 1: M749. https://doi.org/10.3390/M749

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop